Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma
Acta Derm Venereol
.
2020 Nov 26;100(18):adv00335.
doi: 10.2340/00015555-3681.
Authors
Yuri Sakaguchi
1
,
Takaya Komori
,
Megumi Aoki
,
Atsushi Otsuka
,
Kenji Kabashima
,
Shigeto Matsushita
Affiliation
1
Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Shiroyama-cho, Kagoshima, Kagoshima 892-0853 , Japan.
PMID:
33135773
PMCID:
PMC9309830
DOI:
10.2340/00015555-3681
No abstract available
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Dermatitis*
Humans
Ipilimumab / therapeutic use
Melanoma* / drug therapy
Nivolumab / adverse effects
Skin Neoplasms* / drug therapy
Substances
Ipilimumab
Nivolumab